Literature DB >> 33407494

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway.

Wei Zhang1, Yanwei Zhang1, Wensheng Zhou1, Fangfei Qian1, Minjuan Hu1, Ya Chen1, Jun Lu2, Yuqing Lou3, Baohui Han4.   

Abstract

BACKGROUND: Angiogenic placental growth factor (PlGF) plays a role in hypoxia-induced angiogenesis. Here, we aimed to investigate the biological roles of PlGF in cell proliferation and glycolysis of lung adenocarcinoma (LUAD) and the underlying molecular mechanisms.
METHODS: PlGF was knocked down in H358 and H1975 cells by lentiviruses, which were then cultured under hypoxia (90% N2, 5%CO2 and 5%O2) for 24 h. PlGF was overexpressed in PC9 cells treated with XAV939, inhibitor of Wnt/β-catenin signaling pathway. PlGF-silencing H1975 cells were implanted into mice, and tumor xenografts were harvested and analyzed.
RESULTS: Hypoxia treatment led to up-regulation of PlGF, C-myc, lactate dehydrogenase A (LDHA), and β-catenin, promotion of cell proliferation and glycolysis in H358 and H1975 cells, which were obviously reversed by knocking down PlGF. In tumors, PlGF knockdown significantly prohibited cell proliferation and glycolysis, and decreased expression of C-myc, LDHA, and β-catenin. PlGF overexpression markedly strengthened cell proliferation, which was inhibited by β-catenin knockdown. Consistently, XAV939, inhibitor of Wnt/β-catenin pathway, also inhibited PlGF-induced cell proliferation, glycolysis, and β-catenin expression in PC9 cells.
CONCLUSION: PlGF knockdown inhibited the stimulatory effect of hypoxia on cell proliferation and glycolysis of LUAD through deactivating Wnt/β-catenin pathway.

Entities:  

Keywords:  C-myc; Cell proliferation; Glycolysis; Hypoxia; β-catenin

Year:  2021        PMID: 33407494     DOI: 10.1186/s12935-020-01714-w

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  45 in total

Review 1.  HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.

Authors:  Shanmugasundaram Ganapathy-Kanniappan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-04-08       Impact factor: 10.680

Review 3.  Negative and positive regulation of HIF-1: a complex network.

Authors:  Julia I Bárdos; Margaret Ashcroft
Journal:  Biochim Biophys Acta       Date:  2005-07-25

Review 4.  Hypoxia Mediates Tumor Malignancy and Therapy Resistance.

Authors:  Weibo Luo; Yingfei Wang
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.

Authors:  Sepideh Izadi; Asma Moslehi; Hadiseh Kheiry; Fariba Karoon Kiani; Armin Ahmadi; Ali Masjedi; Sepideh Ghani; Behnam Rafiee; Vahid Karpisheh; Farnaz Hajizadeh; Fatemeh Atyabi; Akram Assali; Farnaz Sadat Mirzazadeh Tekie; Afshin Namdar; Ghasem Ghalamfarsa; Mozhdeh Sojoodi; Farhad Jadidi-Niaragh
Journal:  Pharm Res       Date:  2020-09-17       Impact factor: 4.200

6.  Molecular landmarks of tumor hypoxia across cancer types.

Authors:  Vinayak Bhandari; Christianne Hoey; Lydia Y Liu; Emilie Lalonde; Jessica Ray; Julie Livingstone; Robert Lesurf; Yu-Jia Shiah; Tina Vujcic; Xiaoyong Huang; Shadrielle M G Espiritu; Lawrence E Heisler; Fouad Yousif; Vincent Huang; Takafumi N Yamaguchi; Cindy Q Yao; Veronica Y Sabelnykova; Michael Fraser; Melvin L K Chua; Theodorus van der Kwast; Stanley K Liu; Paul C Boutros; Robert G Bristow
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

Review 7.  Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives.

Authors:  Joana Mesquita; João Paulo Castro-de-Sousa; Sara Vaz-Pereira; Arminda Neves; Luís A Passarinha; Cândida T Tomaz
Journal:  Cytokine Growth Factor Rev       Date:  2017-12-07       Impact factor: 7.638

Review 8.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.

Authors:  Barbara Muz; Pilar de la Puente; Feda Azab; Abdel Kareem Azab
Journal:  Hypoxia (Auckl)       Date:  2015-12-11

Review 9.  Hypoxia and Selective Autophagy in Cancer Development and Therapy.

Authors:  Ioanna Daskalaki; Ilias Gkikas; Nektarios Tavernarakis
Journal:  Front Cell Dev Biol       Date:  2018-09-10
View more
  1 in total

1.  Hypoxia is fine-tuned by Hif-1α and regulates mesendoderm differentiation through the Wnt/β-Catenin pathway.

Authors:  Xiaopeng Shen; Meng Li; Chunguang Wang; Zhongxian Liu; Kun Wu; Ao Wang; Chao Bi; Shan Lu; Hongan Long; Guoping Zhu
Journal:  BMC Biol       Date:  2022-10-05       Impact factor: 7.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.